ESIH:F:F-Ishares VI PLC - Ishares Msci Europe Health Care Sector Ucits ETF (EUR)

ETF | Others |

Last Closing

USD 7.125

Change

-0.04 (-0.57)%

Market Cap

USD 0.60B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.94 (+1.90%)

USD 115.48B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.93 (+1.73%)

USD 95.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 88.54B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.35 (+1.61%)

USD 75.49B
EUNL:F iShares Core MSCI World UCITS ..

+0.44 (+0.47%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.70 (+1.19%)

USD 56.16B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.27 (+1.81%)

USD 56.02B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.01 (+0.01%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.04 (+0.04%)

USD 51.63B

ETFs Containing ESIH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.81% 80% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.81% 78% C+ 65% D
Trailing 12 Months  
Capital Gain 10.86% 53% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.86% 51% F 54% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.27% 56% F 58% F
Dividend Return 3.27% 54% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 5.12% 85% B 95% A
Risk Adjusted Return 63.80% 86% B+ 88% B+
Market Capitalization 0.60B 65% D 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike